ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)

SEK 20.6

(-4.63%)

Long Term Debt Summary of ExpreS2ion Biotech Holding AB (publ)

  • ExpreS2ion Biotech Holding AB (publ)'s latest annual long term debt in 2023 was 1.43 Million SEK , up 1531.82% from previous year.
  • ExpreS2ion Biotech Holding AB (publ)'s latest quarterly long term debt in 2024 Q2 was - SEK , down 0.0% from previous quarter.
  • ExpreS2ion Biotech Holding AB (publ) reported annual long term debt of 88 Thousand SEK in 2022, down -53.93% from previous year.
  • ExpreS2ion Biotech Holding AB (publ) reported annual long term debt of 191 Thousand SEK in 2021, down -61.1% from previous year.
  • ExpreS2ion Biotech Holding AB (publ) reported quarterly long term debt of 1.38 Million SEK for 2024 Q1, down 0.0% from previous quarter.
  • ExpreS2ion Biotech Holding AB (publ) reported quarterly long term debt of 1.43 Million SEK for 2023 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of ExpreS2ion Biotech Holding AB (publ) (2023 - 2013)

Historical Annual Long Term Debt of ExpreS2ion Biotech Holding AB (publ) (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 1.43 Million SEK 1531.82%
2022 88 Thousand SEK -53.93%
2021 191 Thousand SEK -61.1%
2020 491 Thousand SEK -50.8%
2019 998 Thousand SEK -83.54%
2018 6.06 Million SEK -4.13%
2017 6.32 Million SEK 7.7%
2016 5.87 Million SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%

Peer Long Term Debt Comparison of ExpreS2ion Biotech Holding AB (publ)

Name Long Term Debt Long Term Debt Difference
Alligator Bioscience AB (publ) 7.51 Million SEK 80.894%
Ziccum AB (publ) 286 Thousand SEK -402.098%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK 33.271%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -68.941%
Genovis AB (publ.) 74.8 Million SEK 98.08%
Intervacc AB (publ) 142 Thousand SEK -911.268%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK 52.133%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 95.593%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 97.799%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK 66.574%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -238.679%
Egetis Therapeutics AB (publ) 103.4 Million SEK 98.611%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -43.6%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.847%
Camurus AB (publ) 13.61 Million SEK 89.451%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 94.141%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.83%
Cyxone AB (publ) 74 Thousand SEK -1840.541%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 95.505%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -955.882%
SynAct Pharma AB 58 Thousand SEK -2375.862%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -68.941%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 18.455%
BioInvent International AB (publ) 14.53 Million SEK 90.12%
Alzinova AB (publ) 800 Thousand SEK -79.5%
Oncopeptides AB (publ) 106.48 Million SEK 98.651%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 98.417%
Diamyd Medical AB (publ) 30.67 Million SEK 95.318%
Xbrane Biopharma AB (publ) 112.89 Million SEK 98.728%
Ascelia Pharma AB (publ) 176 Thousand SEK -715.909%
Diagonal Bio AB (publ) - SEK -Infinity%